NCT04531384

Brief Summary

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2020

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 28, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

December 29, 2022

Status Verified

September 1, 2022

Enrollment Period

2 years

First QC Date

August 4, 2020

Last Update Submit

December 28, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes of galvanic skin response during the virtual reality based addiction assessment system

    The galvanic skin response is an emotional physiological indicator, and its unit is ohm.

    in 1 year

Secondary Outcomes (7)

  • Treatment motivation

    in 1 year

  • Anxiety

    in 1 year

  • Depression

    in 1 year

  • Attentional bias related to drugs and emotional stimulation

    in 1 year

  • Risky decision-making

    in 1 year

  • +2 more secondary outcomes

Study Arms (2)

robot-assisted rehabilitation intelligent treatment

EXPERIMENTAL

Participants assigned to this condition were offered 10 weekly individual sessions of robot-assisted rehabilitation treatment, delivered by the Robot-assisted rehabilitation intelligent system. The system contains 10 core cognitive-behavioral therapy (CBT) skill topics (such as functional analysis, coping skills training, reviewing practice exercises, explaining CBT concepts). A robot therapist demonstrates the target CBT skills and assigns homework to participants.

Device: robot-assisted rehabilitation intelligent treatment

treatment as usual

OTHER

Participants in the treatment-as-usual group were offered standard treatment at the compulsory isolated detoxification centers and non-compulsory isolated detoxification institutions, which consisted of weekly group and/or individual therapy, as determined by the clinical team.

Other: standard psychotherapy treatment

Interventions

robot-assisted rehabilitation psychotherapy

robot-assisted rehabilitation intelligent treatment

standard treatment at the compulsory isolated detoxification centers and non-compulsory isolated detoxification institutions

treatment as usual

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders;
  • Education level equal or more than 9 years;
  • Have normal or corrected-to-normal vision;
  • Have normal or corrected-to-normal hearing;
  • Less than 3 months before last drug use;

You may not qualify if:

  • Current substance use (except nicotine or caffeine);
  • History of disease which influence cognition,such as seizure disorder、cerebrovascular disease、head injury or other severe medication conditions;
  • Intelligence quotient less than 70.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Gaojing Rehabilitation Center

Shanghai, 200030, China

RECRUITING

MeSH Terms

Conditions

Amphetamine-Related Disorders

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Min Zhao

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 28, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

December 29, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations